Over the last 12 months, ClearPoint Neuro insiders reported no purchases and 5 sales totaling $1.7M across SEC Form 4 filings. 60% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | BURNETT JOSEPHCEO and President · O·D | ▼ Sale | 20,000 | $19.38 | $388K | -14.6% | plan |
| Jun 17, 2026 | BURNETT JOSEPHCEO and President · O·D | ▼ Sale | 1,843 | $17.94 | $33K | -1% | plan · indirect |
| Jun 17, 2026 | BURNETT JOSEPHCEO and President · O·D | ▼ Sale | 60,000 | $17.79 | $1.1M | -33.9% | plan |
| Jun 1, 2026 | Richards Timothy T.D | ▼ Sale | 5,415 | $12.17 | $66K | -5.8% | — |
| May 21, 2026 | Klein Matthew B.D | ▼ Sale | 16,000 | $11.59 | $185K | -25.4% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CLPT feed.